Carpal Tunnel Syndrome: An Internist's Comprehensive Guide to Diagnosis and Management

Dr Neeraj Manikath , claude.ai

Abstract

Carpal tunnel syndrome (CTS), the most prevalent entrapment neuropathy, presents unique diagnostic and therapeutic challenges for internists. This comprehensive review synthesizes current evidence on epidemiology, pathophysiology, clinical assessment, and management strategies, with emphasis on practical pearls for clinical practice. Understanding CTS is crucial for internists, given its strong associations with systemic diseases including diabetes, thyroid disorders, and rheumatologic conditions. This article provides evidence-based guidance for postgraduate physicians and consultants managing this common condition.

Keywords: Carpal tunnel syndrome, median nerve compression, entrapment neuropathy, electrodiagnostic studies, conservative management

Introduction and Epidemiology

Carpal tunnel syndrome affects approximately 3-6% of adults in the general population, with annual incidence rates of 1-3 cases per 1,000 individuals.¹ The condition demonstrates marked gender disparity, affecting women three times more frequently than men, with peak incidence occurring between ages 40-60 years.² This epidemiological pattern reflects both anatomical factors (smaller carpal tunnel dimensions in women) and hormonal influences on fluid retention and connective tissue compliance.

For internists, CTS represents more than an isolated peripheral nerve disorder—it frequently serves as a sentinel manifestation of systemic disease. The prevalence of CTS increases dramatically in specific populations: 14-30% in diabetic patients, 25-50% in hypothyroid patients, 3-12% in pregnant women, and up to 40% in long-term dialysis patients.³⁻⁴ Recognition and appropriate management of CTS requires integration of neurological assessment with comprehensive evaluation of underlying systemic conditions.

Anatomical Considerations and Pathophysiology

The Carpal Tunnel: Anatomy and Vulnerability

The carpal tunnel represents a rigid osteoligamentous compartment bounded posteriorly by carpal bones (scaphoid, lunate, triquetrum, pisiform, trapezium, trapezoid, capitate, hamate) and anteriorly by the transverse carpal ligament (flexor retinaculum). This 2-3 cm canal accommodates nine flexor tendons (flexor digitorum superficialis and profundus to digits 2-5, plus flexor pollicis longus) along with the median nerve.⁵

Pearl #1: The median nerve occupies a superficial position within the tunnel, lying immediately beneath the transverse carpal ligament. This anatomical relationship makes the nerve particularly susceptible to compression from any space-occupying process or increase in tunnel pressure.

The palmar cutaneous branch of the median nerve typically arises 5-6 cm proximal to the wrist crease and courses superficial to the transverse carpal ligament, providing sensation to the thenar eminence and palmar skin. This explains why isolated carpal tunnel involvement classically spares palmar sensation—though anatomical variations occur in up to 20% of individuals.⁶

Pathophysiological Cascade

CTS pathogenesis involves progressive ischemic injury initiated by elevated intracarpal pressure. Normal resting pressure within the carpal tunnel approximates 2-10 mmHg, increasing to 30-40 mmHg with wrist flexion or extension. In CTS patients, resting pressures often exceed 30 mmHg, reaching 90-110 mmHg during wrist motion.⁷

The pathophysiological sequence progresses through distinct stages:

Initial Phase: Elevated compartment pressure causes venous congestion and reduced arterial perfusion
Intermediate Phase: Chronic ischemia triggers endoneurial edema, increasing nerve diameter and further elevating tunnel pressure
Advanced Phase: Prolonged ischemia causes axonal degeneration, demyelination, and ultimately irreversible nerve damage with thenar muscle atrophy⁸

This explains the clinical observation that nocturnal symptoms predominate—wrist flexion during sleep, combined with increased venous pressure in recumbent positioning, maximally elevates intracarpal pressure.

Clinical Presentation: Classic and Atypical Features

Characteristic Symptoms

Classic CTS presents with paresthesias, numbness, and pain affecting the thumb, index, middle, and radial aspect of the ring finger—corresponding to median nerve sensory distribution. Symptoms typically worsen at night, often awakening patients from sleep.⁹ Many patients report symptom relief with hand shaking or position changes (the "flick sign").

Pearl #2: The "flick sign" demonstrates 93% sensitivity and 96% specificity for CTS.¹⁰ Ask patients: "What do you do when symptoms wake you at night?" The characteristic response involves demonstrating vigorous hand shaking or "flicking" movements.

Atypical Presentations: Critical Oysters

Oyster #1: Proximal Radiation Pattern Approximately 40% of CTS patients experience pain radiating proximally to the forearm, elbow, shoulder, or even neck.¹¹ This "centripetal" pain distribution likely reflects central nervous system sensitization rather than actual proximal nerve compression. Failure to recognize this pattern leads to unnecessary cervical spine imaging and delayed diagnosis.

Oyster #2: Palmar Involvement Despite textbook teaching that CTS spares the palm, 10-20% of patients report palmar symptoms due to anatomical variations in palmar cutaneous branch anatomy or associated inflammatory tenosynovitis.¹² Don't dismiss CTS diagnosis based solely on palmar complaints.

Oyster #3: Motor Symptoms Without Sensory Complaints While sensory symptoms typically precede motor involvement, approximately 5-10% of patients present primarily with weakness, clumsiness, or dropping objects—particularly elderly individuals with diminished sensory perception.¹³ Isolated motor CTS requires high clinical suspicion.

Oyster #4: Bilateral Asymmetric Presentation Though CTS commonly affects both hands, symptom severity often differs substantially between sides. The dominant hand typically demonstrates more severe involvement, likely reflecting cumulative repetitive strain.¹⁴

Physical Examination: Optimizing Diagnostic Accuracy

Sensory Examination

Light touch and pinprick sensation should be assessed in median nerve distribution, comparing affected digits to ulnar-innervated digits. Two-point discrimination testing (normal <6mm) provides quantitative assessment of nerve function. Abnormal two-point discrimination indicates significant axonal loss and correlates with worse surgical outcomes.¹⁵

Hack #1: Use a bent paperclip for two-point discrimination testing—readily available, consistent, and adequate for clinical assessment.

Motor Examination

Evaluate thenar muscle bulk bilaterally. Visible thenar atrophy indicates advanced disease with substantial nerve damage. Test thumb abduction strength (abductor pollicis brevis, pure median nerve innervation) by asking patients to point their thumb toward the ceiling against resistance while the hand rests palm-up on a table.

Pearl #3: The "pen test" for abductor pollicis brevis weakness: Ask the patient to grasp a pen between their thumb pad and index finger lateral surface (key pinch). Weakness causes patients to compensate by flexing the thumb interphalangeal joint (flexor pollicis longus, anterior interosseous nerve) rather than maintaining extension—a subtle but specific finding.¹⁶

Provocative Maneuvers

Tinel's Sign (Sensitivity 50%, Specificity 77%)¹⁷ Light percussion over the median nerve at the wrist crease should reproduce paresthesias distally. Perform correctly with gentle tapping—forceful percussion causes non-specific discomfort in healthy individuals.

Phalen's Test (Sensitivity 68%, Specificity 73%)¹⁸ Traditional passive wrist flexion for 60 seconds. However, consider combining with reverse Phalen's (forced wrist extension), which may increase sensitivity.

Durkan's Carpal Compression Test (Sensitivity 87%, Specificity 90%)¹⁹ Direct thumb pressure over the median nerve at the proximal wrist crease for 30 seconds, reproducing characteristic symptoms. This test outperforms both Tinel's and Phalen's in diagnostic accuracy.

Hand Elevation Test (Sensitivity 76%, Specificity 99%)²⁰ Patients elevate both arms overhead with wrists extended for 60 seconds. Positive when characteristic median nerve symptoms develop within this timeframe. This test may offer the highest specificity of all provocative maneuvers.

Hack #2: Combine provocative tests to maximize diagnostic confidence. The presence of three positive tests increases post-test probability to >90% even without electrodiagnostic confirmation.²¹

Diagnostic Evaluation

Electrodiagnostic Studies: The Gold Standard

Nerve conduction studies (NCS) and electromyography (EMG) remain the diagnostic gold standard, with sensitivity 85-90% and specificity >95%.²² Key findings include:

Prolonged median sensory latency (>3.5-3.7 ms across 13-14 cm)
Prolonged median motor distal latency (>4.2-4.4 ms)
Reduced sensory nerve action potential amplitude (<10-15 μV)
Normal ulnar and radial nerve studies (excluding polyneuropathy)

Severity classification guides management:

Mild: Isolated prolonged sensory latency
Moderate: Prolonged sensory and motor latencies
Severe: Absent sensory responses with denervation on EMG²³

Oyster #5: The False-Negative NCS Up to 10-15% of clinically definite CTS cases demonstrate normal electrodiagnostic studies, particularly in early disease or intermittent compression.²⁴ Clinical diagnosis supersedes electrophysiological findings when history and examination strongly suggest CTS.

Pearl #4: Request "internal comparison studies" with radial and ulnar nerves tested simultaneously. Median-to-ulnar latency differences >0.4 ms increase diagnostic confidence and help exclude polyneuropathy.²⁵

Ultrasound Evaluation

High-resolution ultrasonography demonstrates 77-87% sensitivity and 86-97% specificity for CTS diagnosis.²⁶ Key sonographic findings include:

Median nerve cross-sectional area >10-13 mm² at pisiform level
Flattening ratio (anteroposterior:mediolateral diameter) >0.7
Notch sign (indentation at tunnel inlet)
Increased nerve vascularity on Doppler imaging

Ultrasound advantages include identification of structural abnormalities (ganglion cysts, bifid median nerve, persistent median artery), dynamic assessment during wrist motion, and guidance for therapeutic injections.²⁷

MRI Evaluation

MRI remains reserved for atypical presentations, suspected space-occupying lesions, or surgical planning. T2-weighted sequences demonstrate increased median nerve signal intensity, nerve swelling, and palmar bowing of the flexor retinaculum.²⁸

Differential Diagnosis: Avoiding Diagnostic Pitfalls

C6-C7 Radiculopathy

Differentiated by neck pain radiating distally, weakness in C6/C7 myotomes (wrist extensors, triceps), diminished reflexes, and provocative neck maneuvers. Spurling's test (neck extension with ipsilateral rotation and axial compression) reproduces radicular symptoms.

Oyster #6: Double Crush Syndrome Concurrent proximal nerve compression (cervical radiculopathy) and distal compression (CTS) occurs in 3-6% of patients.²⁹ This explains why some CTS patients respond incompletely to carpal tunnel release. Consider cervical spine evaluation when CTS patients demonstrate atypical features or suboptimal treatment responses.

Pronator Syndrome

Median nerve compression at the proximal forearm presents with similar sensory symptoms but includes forearm pain, tenderness over pronator teres, pain with resisted pronation, and symptoms with elbow flexion rather than wrist flexion.³⁰

Diabetic Polyneuropathy

Characterized by symmetric stocking-glove distribution, absent ankle reflexes, and involvement of non-median nerve territories. However, diabetic patients have 2-4 times higher CTS prevalence, frequently complicating the clinical picture.³¹

Hack #3: In diabetic patients with hand numbness, always assess ankle reflexes and foot sensation. Preserved ankle reflexes with isolated hand symptoms favor CTS over polyneuropathy.

Thoracic Outlet Syndrome

Affects C8-T1 nerve roots (ulnar-sided symptoms), worsens with arm elevation/abduction, and may include vascular symptoms (arm swelling, discoloration). Provocative maneuvers (Adson's, Wright's tests) help differentiate.³²

Conservative Management: Evidence-Based Strategies

Wrist Splinting (Level A Evidence)

Neutral-position wrist splinting, particularly during sleep, improves symptoms in 60-80% of mild-to-moderate CTS patients.³³ Splints prevent nocturnal wrist flexion—the primary pathophysiological contributor to symptoms. Optimal duration: minimum 4-6 weeks of consistent use.

Pearl #5: Emphasize that splints should maintain the wrist in neutral position (0-5 degrees extension), not hyperextension. Excessive extension increases carpal tunnel pressure, potentially worsening symptoms.³⁴

Corticosteroid Injection (Level A Evidence)

Local corticosteroid injection provides significant symptom relief in 70-80% of patients at one month, though benefit diminishes over time (30-40% at six months).³⁵ Optimal technique involves injection proximal to the distal wrist crease, ulnar to palmaris longus tendon (or between flexor carpi radialis and flexor digitorum superficialis when palmaris is absent), directed at 30-45 degrees toward the fingers.

Typical regimen: 1 mL of 40 mg/mL methylprednisolone (or equivalent) mixed with 1 mL of 1% lidocaine.

Hack #4: Pre-treat injection sites with eutectic mixture of local anesthetic (EMLA) cream 45-60 minutes before injection. This significantly improves patient comfort and satisfaction.³⁶

Pearl #6: Ultrasound-guided injection improves accuracy and reduces risk of median nerve injury. Consider referral for ultrasound-guided injection when expertise is available.³⁷

Oral Corticosteroids (Level B Evidence)

Short-course oral prednisone (20 mg daily for 10-14 days) provides comparable short-term benefit to local injection in mild-to-moderate CTS.³⁸ Consider as first-line therapy for needle-phobic patients or when multiple sites require treatment.

NSAIDs and Diuretics (Level C Evidence)

Despite widespread empiric use, NSAIDs demonstrate minimal benefit specifically for CTS symptoms, though they may help associated conditions like tenosynovitis or arthritis.³⁹ Similarly, diuretics show limited evidence for CTS-specific efficacy.

Nerve and Tendon Gliding Exercises (Level B Evidence)

Structured physical therapy programs incorporating nerve gliding exercises, tendon gliding, and manual therapy provide modest symptomatic benefit, particularly when combined with splinting.⁴⁰ Exercises aim to improve median nerve excursion through the carpal tunnel and reduce adhesions.

Vitamin B6 Supplementation (Controversial)

Early enthusiasm for pyridoxine supplementation (100-200 mg daily) has not been substantiated by rigorous trials. Current evidence suggests minimal benefit, though supplementation remains safe for patients with documented deficiency.⁴¹

Predictors of Conservative Management Success

Pearl #7: Factors predicting successful non-operative management include:²⁴

Symptom duration <12 months
Intermittent rather than constant symptoms
Normal two-point discrimination
Absence of thenar atrophy
Mild-to-moderate electrodiagnostic severity

Patients lacking these favorable features should be counseled regarding the likelihood of requiring surgical intervention.

Surgical Management: Indications and Outcomes

Surgical Indications

Failed conservative management after 6-12 weeks
Severe symptoms significantly affecting daily activities or quality of life
Objective evidence of median nerve compromise (thenar atrophy, weakness, abnormal two-point discrimination)
Severe electrodiagnostic findings (absent sensory responses, denervation)
Patient preference for definitive treatment⁴²

Surgical Techniques

Open Carpal Tunnel Release: Traditional approach with 90-95% success rate, involving longitudinal incision and direct visualization of median nerve during transverse carpal ligament division.⁴³

Endoscopic Carpal Tunnel Release: Minimally invasive technique offering faster recovery and earlier return to work (by 7-14 days) but no long-term outcome differences compared to open approach. Higher risk of incomplete release and nerve injury in less-experienced hands.⁴⁴

Ultrasound-Guided Release: Emerging technique showing promise in selected cases, though long-term outcome data remain limited.⁴⁵

Prognostic Factors

Pearl #8: Surgical outcomes correlate inversely with:⁴⁶

Preoperative electrodiagnostic severity
Duration of symptoms before surgery
Patient age (older patients have slower recovery)
Presence of diabetes or other systemic conditions

Patients with severe, longstanding CTS (>2 years) should have realistic expectations regarding incomplete sensory recovery, though pain typically improves dramatically.

Special Populations and Systemic Associations

Pregnancy-Associated CTS

Affects 35-62% of pregnant women, typically manifesting in the third trimester due to fluid retention and hormonal effects on connective tissue.⁴⁷ Management prioritizes conservative measures (splinting, activity modification), as most cases resolve spontaneously within 3 months postpartum. Surgery should be deferred unless severe symptoms persist beyond this timeframe.

Hack #5: For pregnant patients with CTS, emphasize that symptoms will likely resolve after delivery. This reassurance often improves patient satisfaction and compliance with conservative treatment.

Diabetes Mellitus

Diabetic patients demonstrate 2-4 times higher CTS prevalence, likely reflecting multiple mechanisms including metabolic factors, glycosylation of connective tissue, microvascular changes, and increased susceptibility to nerve compression.⁴⁸ These patients experience worse surgical outcomes and higher recurrence rates. Optimize glycemic control before surgical intervention.

Oyster #7: Diabetic patients with hand numbness present a diagnostic dilemma—distinguishing CTS from diabetic polyneuropathy requires careful examination (asymmetric vs. symmetric distribution, preserved vs. absent ankle reflexes) and often electrodiagnostic confirmation.

Hypothyroidism

CTS affects 25-50% of hypothyroid patients due to myxedematous infiltration of the carpal tunnel and surrounding tissues.⁴⁹ Thyroid hormone replacement often improves symptoms, though some patients require additional interventions. Always assess thyroid function in newly diagnosed CTS, particularly in women over age 40.

Rheumatoid Arthritis

Tenosynovial proliferation in RA creates unique challenges. Prevalence reaches 50-70% in established disease.⁵⁰ Optimize disease-modifying antirheumatic therapy before considering surgery. Higher recurrence rates necessitate closer follow-up.

Dialysis-Related Amyloidosis

Long-term hemodialysis patients (>10 years) develop CTS from beta-2 microglobulin amyloid deposition.⁵¹ Conservative management proves largely ineffective. Early surgical intervention is recommended, though progression may continue due to ongoing amyloid accumulation.

Acromegaly

CTS occurs in 50-70% of acromegalic patients due to soft tissue overgrowth and nerve hypertrophy.⁵² Treatment of underlying acromegaly may improve symptoms, though many patients ultimately require surgical decompression.

Emerging Concepts and Future Directions

Metabolic Syndrome and Obesity

Recent research emphasizes associations between CTS and metabolic syndrome components including obesity, insulin resistance, and dyslipidemia.⁵³ Weight loss and metabolic optimization may reduce CTS progression risk—an important counseling point for overweight patients.

Platelet-Rich Plasma (PRP) Injection

Preliminary evidence suggests PRP injections may provide longer-lasting symptom relief compared to corticosteroids (sustained improvement at 6 months), potentially through anti-inflammatory and regenerative mechanisms.⁵⁴ However, optimal protocols and long-term outcomes require further investigation.

Perineural Hydrodissection

Ultrasound-guided injection of 5% dextrose or normal saline around the median nerve aims to mechanically separate nerve from surrounding tissues and reduce adhesions.⁵⁵ Early studies show promise, though definitive evidence awaits larger controlled trials.

Regenerative Medicine Approaches

Nerve growth factor, stem cell therapy, and tissue engineering represent potential future interventions, though all remain experimental.⁵⁶

Practical Clinical Algorithm

A systematic approach optimizes CTS management:

1. Clinical Assessment

Detailed history emphasizing nocturnal symptoms, flick sign, functional limitations
Comprehensive physical examination including provocative tests
Screen for systemic associations (diabetes, thyroid, pregnancy, RA)

2. Diagnostic Confirmation

Electrodiagnostic studies for most patients (except obvious cases requiring urgent surgery)
Consider ultrasound for structural evaluation or injection guidance
Reserve MRI for atypical presentations

3. Initial Management (Mild-to-Moderate Cases)

Nocturnal wrist splinting in neutral position (6-12 weeks)
Consider corticosteroid injection (local or oral)
Activity modification and ergonomic assessment
Patient education regarding natural history and prognosis

4. Reassessment

Evaluate response at 6-12 weeks
If inadequate improvement, consider repeat injection or surgical referral
Address underlying systemic conditions throughout

5. Surgical Referral

Failed conservative management
Severe symptoms or objective nerve compromise
Patient preference for definitive treatment

6. Postoperative Care

Early mobilization with gentle range-of-motion exercises
Gradual return to activities over 4-8 weeks
Monitor for complications (incomplete release, nerve injury, pillar pain, scar tenderness)

Conclusion

Carpal tunnel syndrome represents far more than an isolated peripheral nerve disorder—it serves as a window into systemic health and metabolic status. For internists, successful CTS management requires integration of neurological assessment skills with comprehensive evaluation of underlying medical conditions. Recognition of classic and atypical presentations, judicious use of diagnostic modalities, evidence-based conservative management, and appropriate surgical referral timing optimize patient outcomes.

The principles outlined in this review—emphasizing clinical pearls, recognizing oysters, and employing practical hacks—should enhance the internist's diagnostic acuity and therapeutic effectiveness. As our understanding of CTS pathophysiology evolves and novel therapeutics emerge, maintaining current knowledge becomes increasingly important.

Ten Key Take-Home Points:

The flick sign offers excellent diagnostic accuracy (93% sensitivity, 96% specificity)
Normal electrodiagnostic studies don't exclude clinical CTS—clinical diagnosis supersedes
Durkan's test and hand elevation test outperform traditional Tinel's and Phalen's maneuvers
Proximal pain radiation occurs in 40% of patients—don't let this mislead you
Nocturnal neutral-position splinting remains first-line therapy with 60-80% efficacy
Corticosteroid injection (local or oral) provides 70-80% short-term success
Always screen for systemic associations—diabetes, hypothyroidism, pregnancy, RA
Two-point discrimination and thenar atrophy indicate severe disease requiring prompt surgical consideration
Surgical outcomes worsen with prolonged preoperative symptom duration—don't delay unnecessarily
Address underlying systemic conditions for optimal long-term outcomes

Ultimately, successful CTS management balances clinical judgment, evidence-based medicine, patient preferences, and realistic expectations—hallmarks of excellent internal medicine practice.

References

Atroshi I, Gummesson C, Johnsson R, et al. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999;282(2):153-158.
Nordstrom DL, DeStefano F, Vierkant RA, et al. Incidence of diagnosed carpal tunnel syndrome in a general population. Epidemiology. 1998;9(3):342-345.
Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25(3):565-569.
Shiri R. Hypothyroidism and carpal tunnel syndrome: a meta-analysis. Muscle Nerve. 2014;50(6):879-883.
Papanas N, Maltezos E. The diabetic hand: a forgotten complication? J Diabetes Complications. 2010;24(3):154-162.
Lanz U. Anatomical variations of the median nerve in the carpal tunnel. J Hand Surg Am. 1977;2(1):44-53.
Lundborg G, Gelberman RH, Minteer-Convery M, et al. Median nerve compression in the carpal tunnel—functional response to experimentally induced controlled pressure. J Hand Surg Am. 1982;7(3):252-259.
Mackinnon SE. Pathophysiology of nerve compression. Hand Clin. 2002;18(2):231-241.
Stevens JC, Sun S, Beard CM, et al. Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology. 1988;38(1):134-138.
Pryse-Phillips WE. Validation of a diagnostic sign in carpal tunnel syndrome. J Neurol Neurosurg Psychiatry. 1984;47(8):870-872.
Seror P. Symptoms of thoracic outlet syndrome in women with carpal tunnel syndrome. Clin Neurophysiol. 2005;116(10):2324-2329.
Hobbs RA, Magnussen PA, Tonkin MA. Palmar cutaneous branch of the median nerve. J Hand Surg Am. 1990;15(1):38-43.
Werner RA, Andary M. Carpal tunnel syndrome: pathophysiology and clinical neurophysiology. Clin Neurophysiol. 2002;113(9):1373-1381.
de Krom MC, Knipschild PG, Kester AD, et al. Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol. 1992;45(4):373-376.
Gellman H, Gelberman RH, Tan AM, Botte MJ. Carpal tunnel syndrome. An evaluation of the provocative diagnostic tests. J Bone Joint Surg Am. 1986;68(5):735-737.
Coert JH, Hoogvliet P, Rosati M. Surgical treatment of carpal tunnel syndrome. Pract Neurol. 2021;21(3):194-200.
D'Arcy CA, McGee S. The rational clinical examination. Does this patient have carpal tunnel syndrome? JAMA. 2000;283(23):3110-3117.
Kuschner SH, Ebramzadeh E, Johnson D, et al. Tinel's sign and Phalen's test in carpal tunnel syndrome. Orthopedics. 1992;15(11):1297-1302.
Durkan JA. A new diagnostic test for carpal tunnel syndrome. J Bone Joint Surg Am. 1991;73(4):535-538.
Ahn DS. Hand elevation test: a new provocative test for carpal tunnel syndrome. Ann Plast Surg. 2001;46(2):120-124.
Katz JN, Stirrat CR. A self-administered hand diagram for the diagnosis of carpal tunnel syndrome. J Hand Surg Am. 1990;15(2):360-363.
American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. Muscle Nerve. 2002;25(6):918-922.
Stevens JC. AAEM minimonograph #26: the electrodiagnosis of carpal tunnel syndrome. Muscle Nerve. 1997;20(12):1477-1486.
Bland JD. Clinical surveillance of carpal tunnel syndrome in two areas of the United Kingdom, 1991-2001. J Neurol Neurosurg Psychiatry. 2003;74(12):1674-1679.
Uncini A, Lange DJ, Solomon M, et al. Ring finger testing in carpal tunnel syndrome: a comparative study of diagnostic utility. Muscle Nerve. 1989;12(9):735-741.
Fowler JR, Gaughan JP, Ilyas AM. The sensitivity and specificity of ultrasound for the diagnosis of carpal tunnel syndrome: a meta-analysis. Clin Orthop Relat Res. 2011;469(4):1089-1094.
Tagliafico A, Cadoni A, Fisci E, et al. Reliability of sonographic anatomy of the median nerve in the carpal tunnel: comparison of measurements in volunteers. J Ultrasound Med. 2010;29(10):1445-1453.
Jarvik JG, Yuen E, Haynor DR, et al. MR nerve imaging in a prospective cohort of patients with suspected carpal tunnel syndrome. Neurology. 2002;58(11):1597-1602.
Upton AR, McComas AJ. The double crush in nerve entrapment syndromes. Lancet. 1973;2(7825):359-362.
Hartz CR, Linscheid RL, Gramse RR, Daube JR. The pronator teres syndrome: compressive neuropathy of the median nerve. J Bone Joint Surg Am. 1981;63(6):885-890.
Vinik A, Mehrabyan A, Colen L, Boulton A. Focal entrapment neuropathies in diabetes. Diabetes Care. 2004;27(7):1783-1788.
Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet syndrome. J Vasc Surg. 2007;46(3):601-604.
Gerritsen AA, de Vet HC, Scholten RJ, et al. Splinting vs surgery in the treatment of carpal tunnel syndrome: a randomized controlled trial. JAMA. 2002;288(10):1245-1251.
Manente G, Torrieri F, Di Blasio F, et al. An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle Nerve. 2001;24(8):1020-1025.
Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007;(2):CD001554.
Karadag O, Kalyoncu U, Akdogan A, et al. Sonography-guided versus blind steroid injection in carpal tunnel syndrome: a single-blind randomized prospective study. Clin Rheumatol. 2012;31(9):1305-1309.
Eslamian F, Eftekharsadat B, Babaei-Ghazani A, et al. A randomized prospective comparison of ultrasound-guided and landmark-guided steroid injections in the treatment of carpal tunnel syndrome. J Clin Neurophysiol. 2017;34(2):107-113.
Chang MH, Chiang HT, Lee SS, et al. Oral drug of choice in carpal tunnel syndrome. Neurology. 1998;51(2):390-393.
Piazzini DB, Aprile I, Ferrara PE, et al. A systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil. 2007;21(4):299-314.
Page MJ, O'Connor D, Pitt V, Massy-Westropp N. Therapeutic ultrasound for carpal tunnel syndrome. Cochrane Database Syst Rev. 2013;(3):CD009601.
Aufiero E, Stitik TP, Foye PM, Chen B. Pyridoxine hydrochloride treatment of carpal tunnel syndrome: a review. Nutr Rev. 2004;62(3):96-104.
Keith MW, Masear V, Chung KC, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of carpal tunnel syndrome. J Bone Joint Surg Am. 2010;92(1):218-219.
Scholten RJ, Mink van der Molen A, Uitdehaag BM, et al. Surgical treatment options for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007;(4):CD003905.
Vasiliadis HS, Georgoulas P, Shrier I, et al. Endoscopic release for carpal tunnel syndrome. Cochrane Database Syst Rev. 2014;(1):CD008265.
Rojo-Manaute JM,

Capa-Grasa A, Chana-Rodriguez F, et al. Ultra-minimally invasive sonographically guided carpal tunnel release: anatomic study of a new technique. J Ultrasound Med. 2013;32(1):131-142.

Bland JD. Treatment of carpal tunnel syndrome. Muscle Nerve. 2007;36(2):167-171.
Padua L, Di Pasquale A, Pazzaglia C, et al. Systematic review of pregnancy-related carpal tunnel syndrome. Muscle Nerve. 2010;42(5):697-702.
Mondelli M, Rossi S, Greco G, et al. Long term follow-up of carpal tunnel syndrome during pregnancy: a cohort study and review of the literature. Electromyogr Clin Neurophysiol. 2007;47(6):259-271.
Karne SS, Bhalerao NS. Carpal tunnel syndrome in hypothyroidism. J Clin Diagn Res. 2016;10(2):OC36-OC38.
Nakamichi K, Tachibana S. Restricted motion of the median nerve in carpal tunnel syndrome. J Hand Surg Br. 1995;20(4):460-464.
Kuntz D, Naveau B, Bardin T, et al. Destructive spondylarthropathy in hemodialyzed patients. A new syndrome. Arthritis Rheum. 1984;27(4):369-375.
Jenkins PJ, Sohaib SA, Akker S, et al. The pathology of median neuropathy in acromegaly. Ann Intern Med. 2000;133(3):197-201.
Shiri R, Pourmemari MH, Falah-Hassani K, Viikari-Juntura E. The effect of excess body mass on the risk of carpal tunnel syndrome: a meta-analysis of 58 studies. Obes Rev. 2015;16(12):1094-1104.
Wu YT, Ho TY, Chou YC, et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Sci Rep. 2017;7:94.
Lam SKH, Reeves KD, Cheng AL. Transition from deep regional blocks toward deep nerve hydrodissection in the upper body and torso: method description and results from a retrospective chart review of the effectiveness of 5% dextrose water as sole primary hydrodissection injectate. Biomed Res Int. 2017;2017:7920438.
Gordon T. Electrical stimulation to enhance axon regeneration after peripheral nerve injuries in animal models and humans. Neurotherapeutics. 2016;13(2):295-310.